- Home
- SABA vs STIM Comparison
SABA vs STIM Comparison
Compare SABA & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABA
- STIM
- Stock Information
- Founded
- SABA 1988
- STIM 2003
- Country
- SABA United States
- STIM United States
- Employees
- SABA N/A
- STIM N/A
- Industry
- SABA
- STIM Medical/Dental Instruments
- Sector
- SABA
- STIM Health Care
- Exchange
- SABA Nasdaq
- STIM Nasdaq
- Market Cap
- SABA 233.0M
- STIM 232.3M
- IPO Year
- SABA N/A
- STIM 2018
- Fundamental
- Price
- SABA $8.24
- STIM $3.76
- Analyst Decision
- SABA
- STIM Buy
- Analyst Count
- SABA 0
- STIM 4
- Target Price
- SABA N/A
- STIM $6.00
- AVG Volume (30 Days)
- SABA 290.0K
- STIM 1.1M
- Earning Date
- SABA 01-01-0001
- STIM 05-06-2025
- Dividend Yield
- SABA 12.91%
- STIM N/A
- EPS Growth
- SABA N/A
- STIM N/A
- EPS
- SABA N/A
- STIM N/A
- Revenue
- SABA N/A
- STIM $74,890,000.00
- Revenue This Year
- SABA N/A
- STIM $102.36
- Revenue Next Year
- SABA N/A
- STIM $9.83
- P/E Ratio
- SABA N/A
- STIM N/A
- Revenue Growth
- SABA N/A
- STIM 4.96
- 52 Week Low
- SABA $3.64
- STIM $0.52
- 52 Week High
- SABA $4.42
- STIM $5.92
- Technical
- Relative Strength Index (RSI)
- SABA 43.48
- STIM 45.71
- Support Level
- SABA $8.10
- STIM $3.46
- Resistance Level
- SABA $8.40
- STIM $4.14
- Average True Range (ATR)
- SABA 0.27
- STIM 0.40
- MACD
- SABA 0.00
- STIM -0.00
- Stochastic Oscillator
- SABA 48.15
- STIM 56.52
About SABA Saba Capital Income & Opportunities Fund II Shares of Beneficial Interest
Saba Capital Income & Opportunities Fund II is a closed-end fund. The company seeks high current income, with a secondary goal of capital appreciation. The fund invests in fixed income markets across the globe.
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.